4 Undervalued Personal Care Products Stocks for Tuesday, November 19
Discover the top 4 undervalued Personal Care Products stocks for Tuesday, November 19 based on AAII’s Stock Grades.Aneeqa Nadeem
A+ Stock Grade Summary:
| VALUE: |
|
|
| GROWTH: |
|
|
| MOMENTUM: |
|
|
| EPS REVISIONS: |
|
|
| QUALITY: |
|
|
COMPANY SUMMARY
PMGC Holdings Inc., doing business as NorthStrive Holdings, Inc, a biopharmaceutical company, focuses on the development and acquisition of aesthetic medicines and therapeutic products. It operates through three segments: corporate, treasury and biosciences; IT packaging solutions; and precision engineering and machining. The company’s lead product includes EL-22, a first-in-class engineered probiotic approach to address obesity’s pressing issue of preserving muscle while on weight loss treatments, including GLP-1 receptor agonists. It is also involved in the medical scientific research and development activities, as well as operating investment firms; providing packaging solutions to industrial and consumer markets; and design and production of high-tolerance components for industrial and technological applications. The company was formerly known as Elevai Labs, Inc. and changed its name to PMGC Holdings Inc. in December 2024. PMGC Holdings Inc. was incorporated in 2020 and is based in Newport Beach, California.
Commentary & Analysis
3 Undervalued Personal Care Products Stocks for Thursday, October 17
Discover the top 3 undervalued Personal Care Products stocks for Thursday, October 17 based on AAII’s Stock Grades.Jenna Brashear
Financial Summary
| Share Statistics | ELAB | Industry Median |
Percentile (All Stocks) |
|
| Market Cap (Mil) | $2.2 | $233.2 | 2% |
|
| Shares Out (Mil) | 0.5 | 22.7 | 3% |
|
| Institutional Ownership | 100.0% | 59.6% | 99% |
|
| Float (Mil) | 0.8 | 31.5 | 2% |
|
| Beta | -0.25 | 0.61 | 3% |
|
| Avg Daily Volume (000s) | 8 | 96 | 16% |
|
| Price Change (52-week) |
(99.8%) | 57.8% | 1% |
|
| Growth | ELAB | Industry Median |
Percentile (All Stocks) |
|
| Sales (5yr) | na | 0.7% | na |
|
| Net Income (5yr) | (138.4%) | (8.8%) | 1% |
|
| EPS (5yr) | na | (2.3%) | na |
|
| Dividends (5yr) | na | 0.0% | 0% |
|
| Cash Flow (5yr) | na | (16.8%) | na |
|
| Estimates | Qtrly | Current Fiscal Year |
Next Fiscal Year |
|
| # of Estimates | na | na | na | |
| Current EPS | na | na | na | |
| Month Ago EPS | na | na | na | |
| # Rev Up | na | na | na | |
| # Rev Down | na | na | na | |
| Three Months Ago EPS | na | na | na | |
| Year/Year Chg | na | na | na | |
| Financials | ELAB | Industry Median |
Percentile (All Stocks) |
|
| Sales (TTM) (Mil) | $3 | $650 | 4% |
|
| Net Income (TTM) (Mil) | ($14) | $-0 | 27% |
|
| EPS (TTM) | ($99.791) | $0.100 | 1% |
|
| Operating Cash Flow (TTM) (Mil) | ($8) | $27 | 22% |
|
| Net Cash Flow (TTM) (Mil) | $13 | $1 | 58% |
|
| Long-Term Debt (Q1) (Mil) | $5 | $39 | 24% |
|
| Enterprise Value (Q1) (Mil) | $1 | $350 | 4% |
|
| Valuation | ELAB | Industry Median |
Percentile (All Stocks) |
|
| P/B | 0.10 | 1.82 | 2% |
|
| P/E | na | 13.5 | na |
|
| Dividend Yield | 0.0% | 0.0% | 0% |
|
| PEG (5yr hist) | na | 0.5 | na |
|
| Ratios | ELAB | Industry Median |
Percentile (All Stocks) |
|
| Gross Margin | (20.5%) | 61.0% | 3% |
|
| Net Margin | (523.0%) | 1.7% | 2% |
|
| ROA | (58.7%) | (0.3%) | 10% |
|
| ROE | (104.6%) | 0.8% | 9% |
|
| Liabilities to Assets | 54.2% | 48.9% | 47% |
|
| F-Score | 2 | 5 | na |
|
PMGC Holdings Inc. did not pass any screens on 10/23/2026.
